Trials / Active Not Recruiting
Active Not RecruitingNCT03849716
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 266 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 0 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
Primary Objective: To explore associations between biomarkers of atopic dermatitis (AD) and: * Disease state and time course of AD, * Disease state and evolution of selected atopic comorbid conditions, * Effectiveness of specific AD treatments.
Detailed description
The estimated enrollment duration is approximately 2 years, while duration of observation is approximately 5 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood sample | Blood samples obtained for biomarker analyses |
| OTHER | Cheek swab | Cheek swab obtained for genetic analysis |
Timeline
- Start date
- 2019-04-05
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
- First posted
- 2019-02-21
- Last updated
- 2025-07-11
Locations
48 sites across 9 countries: United States, Argentina, Australia, Brazil, Canada, Colombia, France, Mexico, Netherlands
Source: ClinicalTrials.gov record NCT03849716. Inclusion in this directory is not an endorsement.